Menu Close

Totm issues shares to complete $46M International Biometrics acquisition

Totm Technologies has paid $46.1 million to complete the acquisition of the remaining 49 percent stake it did not own in InterBIO, a Singapore holding company that holds 99 percent of International Biometrics.

According to a Tuesday filing, the Singaporean maker of ID management and biometric products satisfied the consideration by issuing 365,365,000 new shares at SG$0.14 apiece to the sellers.

Totm announced the intention to buy the remaining 49 percent of InterBIO in October 2022. At the time, the all-shares deal was valued at S$65.9 million (US$49.46 million).

The company then received the go-ahead to list up to 470,470,000 new shares to compensate parties involved in its buyout of InterBIO last week. The newly issued shares should be listed and quoted in the Singapore Exchange today.

After the acquisition, InterBIO will become a wholly owned subsidiary of Totm, which purchased 51 percent of InterBIO in April 2021. In the same period, Totm changed its name from Yinda Infocomm.

At the time, the company said the move would help it reach the strategic goal of making Totm more diversified and better control costs.

“This move stems from efforts to control cost and restructure the business of the Group away from the provision of telecommunications solutions and services in Singapore and Thailand, which were affected by Covid-19,” reads the filing.

“Since obtaining Shareholders’ approval for the Diversification into the Biometrics Business, the Group took concrete steps to build the architecture for a successful and sustainable Biometrics Business through acquisitions and investments into complementary businesses and technologies.”

Also in Singapore, the Immigration and Checkpoints Authority (ICA) recently deployed iris and face biometrics from Idemia to automated lanes specifically for people in wheelchairs and family groups at Changi Airport. Totm Technologies has paid $46.1 million to complete the acquisition of the remaining 49 percent stake it did not own in InterBIO, a Singapore holding company that holds 99 percent of International Biometrics.

According to a Tuesday filing, the Singaporean maker of ID management and biometric products satisfied the consideration by issuing 365,365,000 new shares at SG$0.14 apiece to the sellers.

Totm announced the intention to buy the remaining 49 percent of InterBIO in October 2022. At the time, the all-shares deal was valued at S$65.9 million (US$49.46 million).

The company then received the go-ahead to list up to 470,470,000 new shares to compensate parties involved in its buyout of InterBIO last week. The newly issued shares should be listed and quoted in the Singapore Exchange today.

After the acquisition, InterBIO will become a wholly owned subsidiary of Totm, which purchased 51 percent of InterBIO in April 2021. In the same period, Totm changed its name from Yinda Infocomm.

At the time, the company said the move would help it reach the strategic goal of making Totm more diversified and better control costs.

“This move stems from efforts to control cost and restructure the business of the Group away from the provision of telecommunications solutions and services in Singapore and Thailand, which were affected by Covid-19,” reads the filing.

“Since obtaining Shareholders’ approval for the Diversification into the Biometrics Business, the Group took concrete steps to build the architecture for a successful and sustainable Biometrics Business through acquisitions and investments into complementary businesses and technologies.”

Also in Singapore, the Immigration and Checkpoints Authority (ICA) recently deployed iris and face biometrics from Idemia to automated lanes specifically for people in wheelchairs and family groups at Changi Airport.  Read More   

Generated by Feedzy

Disclaimer

Innov8 is owned and operated by Rolling Rock Ventures. The information on this website is for general information purposes only. Any information obtained from this website should be reviewed with appropriate parties if there is any concern about the details reported herein. Innov8 is not responsible for its contents, accuracies, and any inaccuracies. Nothing on this site should be construed as professional advice for any individual or situation. This website includes information and content from external sites that is attributed accordingly and is not the intellectual property of Innov8. All feeds ("RSS Feed") and/or their contents contain material which is derived in whole or in part from material supplied by third parties and is protected by national and international copyright and trademark laws. The Site processes all information automatically using automated software without any human intervention or screening. Therefore, the Site is not responsible for any (part) of this content. The copyright of the feeds', including pictures and graphics, and its content belongs to its author or publisher.  Views and statements expressed in the content do not necessarily reflect those of Innov8 or its staff. Care and due diligence has been taken to maintain the accuracy of the information provided on this website. However, neither Innov8 nor the owners, attorneys, management, editorial team or any writers or employees are responsible for its content, errors or any consequences arising from use of the information provided on this website. The Site may modify, suspend, or discontinue any aspect of the RSS Feed at any time, including, without limitation, the availability of any Site content.  The User agrees that all RSS Feeds and news articles are for personal use only and that the User may not resell, lease, license, assign, redistribute or otherwise transfer any portion of the RSS Feed without attribution to the Site and to its originating author. The Site does not represent or warrant that every action taken with regard to your account and related activities in connection with the RSS Feed, including, without limitation, the Site Content, will be lawful in any particular jurisdiction. It is incumbent upon the user to know the laws that pertain to you in your jurisdiction and act lawfully at all times when using the RSS Feed, including, without limitation, the Site Content.  

Close Bitnami banner
Bitnami